In conclusion, we observed that high MCL1 gain was poorer prognostic factor for DFS and OS in later stage of ESCC patients (with lymph node metastasis or stage III-IVa) 29 months later. The gene discussed is MCL1; the disease is esophageal squamous cell carcinoma.